Total submissions: 16
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000527428 | SCV000527080 | benign | not provided | 2020-01-28 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26555887, 28356264, 27296017) |
Invitae | RCV001083558 | SCV000651111 | likely benign | Myofibrillar myopathy 5; Distal myopathy with posterior leg and anterior hand involvement; Hypertrophic cardiomyopathy 26; Dilated Cardiomyopathy, Dominant | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000578034 | SCV000679850 | likely benign | Distal myopathy with posterior leg and anterior hand involvement | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000578087 | SCV000679851 | likely benign | Myofibrillar myopathy 5 | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Phosphorus, |
RCV000577974 | SCV000679852 | likely benign | Hypertrophic cardiomyopathy 26 | 2017-08-01 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000527428 | SCV001143946 | benign | not provided | 2018-12-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356571 | SCV002656830 | likely benign | Cardiovascular phenotype | 2019-01-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV000527428 | SCV003799468 | likely benign | not provided | 2022-09-12 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000527428 | SCV004032769 | likely benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | FLNC: BS1 |
CHEO Genetics Diagnostic Laboratory, |
RCV003486835 | SCV004240668 | benign | Cardiomyopathy | 2022-11-18 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003902565 | SCV004721970 | likely benign | FLNC-related disorder | 2020-08-20 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Clinical Genetics, |
RCV000527428 | SCV001923808 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000527428 | SCV001932570 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000527428 | SCV001955675 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000527428 | SCV001963866 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000527428 | SCV002036054 | likely benign | not provided | no assertion criteria provided | clinical testing |